In the treatment of non-small cell lung cancer (NSCLC) patients with morphine, abnormal increase of morphine 3-glucoside (M3G), as an active metabolite of morphine, upregulated the expression of PD-L1 and ultimately promoted tumor escape [55]. Here, CD274 is linked to non-small cell lung carcinoma.